Research output per year
Research output per year
Personal profile
Biography
Roger Schutgens is a Consultant Haematologist at the University Medical Centre Utrecht. His main responsibilities include care, research and education in the area of benign hematology and clotting diseases. Prof. Schutgens is the Head of at the Van Creveldkliniek, a national expertise center for rare and/or inherited benign hematologic disorders, thrombosis and haemostasis. He completed his medical degree from Catholic University Leuven, Leuven, Belgium and he completed his PhD from Utrecht University, Utrecht, The Netherlands. Prof. Schutgens areas of focus include patients predisposed to bleeding, congenital abnormalities of platelets and hypercoagulable conditions.
Side activities
Advisory Board Member Horizonscan geneesmiddelen ZonMW
Scientific Editor HemaSphere (the EHA journal)
Co-owner general practice 'Huisartsenpraktijk Voordorp'
Education/Academic qualification
Master of epidemiology
2010 → 2015
Award Date: 18 Jun 2015
Medicine (cum laude), KU Leuven
1989 → 1996
External positions
1% maatschapsaandeel - geen - Huisartsenpraktijk Voordorp
1 Jul 2022 → 31 Dec 3999
zie bijlage - inhoudsdeskundige - Zorginstituut Nederland
1 Jan 2019 → 31 Dec 3999
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Disease characteristics and outcomes of acute myeloid leukemia in germline RUNX1 deficiency (Familial Platelet Disorder with associated Myeloid Malignancy)
Ernst, M. P. T., Versluis, J., Valk, P. J. M., Bierings, M., Tamminga, R. Y. J., Hooimeijer, L. H., Döhner, K., Gresele, P., Tawana, K., Langemeijer, S. M. C., Van der Reijden, B. A., Podgornik, H., Sever, M., Tvedt, T. H. A., Vulliamy, T., Fitzgibbon, J., Dokal, I., Baliakas, P., Bastida, J. M. & Pohlkamp, C. & 11 others, , Jan 2025, In: Hemasphere. 9, 1, e70057.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile -
No correlation between thrombin generation and emicizumab levels: implications for monitoring emicizumab therapy
van der Zwet, K., Roest, M., Huskens, D., Schutgens, R. E. G., van Vulpen, L. F. D., Fischer, K. & Urbanus, R. T., Jan 2025, In: Research and practice in thrombosis and haemostasis. 9, 1, p. 1-6 6 p., 102658.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile -
A bispecific antibody approach for the potential prophylactic treatment of inherited bleeding disorders
Gandhi, P. S., Zivkovic, M., Østergaard, H., Bonde, A. C., Elm, T., Løvgreen, M. N., Schluckebier, G., Johansson, E., Olsen, O. H., Olsen, E. H. N., de Bus, I. A., Bloem, K., Alskär, O., Rea, C. J., Bjørn, S. E., Schutgens, R. E., Sørensen, B., Urbanus, R. T. & Faber, J. H., Feb 2024, In: Nature Cardiovascular Research. 3, 2, p. 166-185 20 p.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile2 Downloads (Pure) -
Bleeding disorder of unknown cause: an illustrated review on current practice, knowledge gaps, and future perspectives
Monard, A. L. L., Mussert, C. M. A., van Duijl, T. T., Kruip, M. J. H. A., Henskens, Y. M. C., van den Biggelaar, M., Schutgens, R. E. G., Schols, S. E. M., Fijnvandraat, K. J., Meijer, K., den Exter, P. L., Nieuwenhuizen, L., van Moort, I., Baker, R. I., O'Donnell, J. S., Cnossen, M. H., Heubel-Moenen, F. C. J. I., Nov 2024, In: Research and practice in thrombosis and haemostasis. 8, 8, 23 p., 102625.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile1 Downloads (Pure) -
Congenital fibrinogen disorders: a retrospective clinical and genetic analysis of the Prospective Rare Bleeding Disorders Database
Mohsenian, S., Palla, R., Menegatti, M., Cairo, A., Lecchi, A., Casini, A., Neerman-Arbez, M., Asselta, R., Scardo, S., Siboni, S. M., Blatny, J., Zapletal, O., Schved, J. F., Giansily-Blaizot, M., Halimeh, S., Daoud, M. A., Platokouki, H., Pergantou, H., Schutgens, R. E. G. & Van Haaften-Spoor, M. & 20 others, , 26 Mar 2024, In: Blood Advances. 8, 6, p. 1392-1404 13 p.Research output: Contribution to journal › Article › Academic › peer-review
Prizes
-
Immune tolerance induction (ITI) in Hemophilia A: Role for rFVIII-Fc in inducing tolerance
Boes, M. (Recipient) & Schutgens, R. (Recipient), 18 Dec 2017
Prize: Fellowship awarded competitively